Addiction Psychiatrist Salary in 2026: OBOT, OTP, Dual Diagnosis, and Academic Pay

Addiction psychiatrists are board-certified psychiatrists who have completed an ACGME-accredited one-year fellowship in addiction psychiatry and hold an ABPN Certificate of Added Qualification (CAQ) in Addiction Psychiatry. Their clinical focus spans the full spectrum of substance use disorders — opioid use disorder (OUD), alcohol use disorder (AUD), stimulant use disorder, cannabis use disorder, and benzodiazepine dependence — with particular expertise in co-occurring psychiatric disorders ("dual diagnosis" or "comorbid SUD/psychiatric illness"). The 2023 Mainstreaming Addiction Treatment (MAT) Act eliminated the separate DEA X-waiver requirement that had previously restricted buprenorphine prescribing, meaning all DEA-licensed physicians can now prescribe buprenorphine for OUD treatment; this regulatory change has expanded office-based opioid treatment (OBOT) substantially while maintaining strong demand for addiction psychiatrists who can manage complex dual-diagnosis cases.

Training and Board Certification

The pathway is four years of ACGME-accredited general psychiatry residency followed by one year of addiction psychiatry fellowship. ABPN administers the Addiction Psychiatry subspecialty examination, and the certificate requires MOC renewal. Internal medicine and family medicine physicians can pursue addiction medicine (not addiction psychiatry) certification through ABAM (American Board of Addiction Medicine), which is a separate credential with overlapping scope but without the psychiatric co-occurring disorder expertise that distinguishes addiction psychiatrists from addiction medicine specialists. Addiction psychiatrists are particularly valued in settings where the psychiatric complexity of co-occurring disorders (major depression with AUD, PTSD with OUD, bipolar disorder with stimulant use disorder) requires integrated psychiatric and addiction management — a patient population that addiction medicine physicians and primary care providers are often not equipped to handle without referral.

Key CPT Codes and Billing Models

• Psychiatric evaluation (90791, 90792): Initial comprehensive assessment including substance use history, psychiatric history, trauma assessment, and social determinants; the thorough initial evaluation in addiction psychiatry often spans 90 minutes and justifies 90792 with full complexity billing
• Medication management E&M (99213–99215): Follow-up visits for buprenorphine/naloxone, naltrexone, acamprosate, or disulfiram management; high-complexity decision-making (99215) is frequently justified when managing patients with multiple co-occurring psychiatric diagnoses alongside SUD medications
• Psychotherapy add-on codes (90833, 90836, 90838): Brief supportive psychotherapy, motivational interviewing, or relapse prevention add-ons to E&M visits; frequently used by addiction psychiatrists who integrate therapy into medication management visits rather than splitting between separate providers
• OTP-specific codes (H0014, H0033): Methadone treatment services per diem (H0014) and oral medication administration (H0033) are used in opioid treatment program (OTP/methadone clinic) settings; OTP billing operates under a bundled per-diem model rather than traditional fee-for-service, which affects physician compensation structure
• Crisis intervention (90839–90840): Emergency psychiatric evaluation for acute intoxication, overdose behavioral follow-up, or decompensated co-occurring disorder; used in emergency department addiction consultation services and crisis stabilization units

Salary Ranges by Practice Setting

• Office-based opioid treatment (OBOT) — employed or group practice: $260,000–$380,000; following X-waiver elimination, employed addiction psychiatrists in large primary care or multi-specialty groups manage buprenorphine panels alongside full dual-diagnosis psychiatric care; volume of buprenorphine patients managed affects income significantly — psychiatrists managing 80–120 OBOT patients generate more revenue per clinical half-day than traditional outpatient psychiatry volumes
• Private OBOT practice (solo or small group): $280,000–$450,000+; private practices accepting cash pay or select commercial insurance for OBOT and addiction psychiatry services can generate premium income; cash-pay OBOT is ethically controversial given equity concerns in OUD access, but exists in high-income suburban markets; hybrid models (Medicaid acceptance for medication management, cash for therapy) are more common
• Opioid treatment program (OTP) medical director: $260,000–$360,000; OTPs (methadone clinics) must have a physician medical director under federal regulations (42 CFR Part 8); medical director roles at large multi-site OTP networks (BayMark, BAART, Acadia Healthcare) offer administrative salary supplements above base clinical compensation; DEA Schedule II prescribing authority for methadone in OTP settings requires specific SAMHSA/DEA registration
• Academic addiction psychiatry division: $230,000–$310,000; university-based addiction psychiatry divisions combine clinical work in a dual-diagnosis outpatient program with research (NIH NIDA/NIAAA grants), teaching, and fellowship program direction; academic positions offer research infrastructure, protected time, and PSLF eligibility but lag private practice and OTP salaries significantly
• VA addiction psychiatry: $250,000–$340,000; VA health care system is the largest employer of addiction psychiatrists in the country; VA SUD clinics and PTSD/SUD dual-diagnosis programs have substantial patient volume with competitive Title 38 pay scales; VA positions carry excellent benefits, no malpractice cost, and strong work-life balance through defined FTE models
• Inpatient dual-diagnosis programs: $270,000–$380,000; freestanding behavioral health facilities (Acadia Healthcare, Universal Health Services subsidiaries) that run dual-diagnosis inpatient programs recruit addiction psychiatrists for medical director and attending roles; shift-based scheduling (7-on/7-off models) is increasingly common and appeals to physicians who value schedule predictability
• Emergency department addiction consultation: $280,000–$400,000; ED-initiated buprenorphine programs (pioneered at Yale-New Haven and now replicated at hundreds of EDs nationally) rely on addiction medicine/psychiatry consultants to evaluate patients presenting with overdose or SUD-related emergencies; these positions often combine ED consultation with outpatient OBOT follow-up, creating a bridge care model

Post-X-Waiver Landscape and Income Implications

The elimination of the DEA X-waiver requirement in December 2022 (effective January 2023 under the Mainstreaming Addiction Treatment Act) removed the administrative barrier that had previously required additional DEA registration and training to prescribe buprenorphine. This change has two competing effects on addiction psychiatrist income: (1) primary care physicians and internists who previously deferred OUD management to specialists can now prescribe buprenorphine independently, potentially reducing referrals for uncomplicated OUD; and (2) the expansion of buprenorphine prescribing has brought more patients with complex dual-diagnosis presentations into care — patients whose psychiatric complexity exceeds what primary care can manage — creating increased demand for addiction psychiatrists specifically. The net effect is that addiction psychiatrists who differentiate themselves as dual-diagnosis specialists rather than purely OUD medication managers are more insulated from primary care competition post-waiver elimination. Addiction psychiatrists in academic integrated dual-diagnosis programs and private practices that explicitly market complex co-occurring disorder expertise have continued to see strong demand growth.

What we see at Ava Health

Addiction psychiatry is one of the fastest-growing recruiting categories we see, driven by the intersection of three forces: expanded buprenorphine prescribing creating more complex patient panels that need specialist oversight, continued growth in OTP network consolidation (which needs physician medical directors), and a PTSD/SUD dual-diagnosis patient population in the VA system requiring specialized care. The smallest talent pool in our addiction psychiatry pipeline is for academic division chief and fellowship director roles — these require both clinical expertise and academic track records and typically take 4–6 months to fill. The fastest placements are for OTP medical director roles with large OTP networks, which have clearly defined compensation structures and are willing to move quickly for candidates with ABPN Addiction Psychiatry certification and prior OTP experience. Candidates with both addiction psychiatry and addiction medicine certification are particularly competitive in settings that serve patients across the medical-psychiatric spectrum.

Related: Psychiatrist Salary Guide, Addiction Medicine Physician Salary Guide, Child & Adolescent Psychiatrist Salary Guide, Emergency Medicine Physician Salary Guide.